Search details
1.
Mutations in the telomerase reverse transcriptase promoter and PIK3CA gene are common events in penile squamous cell carcinoma of Italian and Ugandan patients.
Int J Cancer
; 150(11): 1879-1888, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35253909
2.
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Br J Cancer
; 127(8): 1479-1486, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35869143
3.
Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy.
Int J Gynecol Cancer
; 31(1): 110-113, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32796087
4.
Overexpression of ADAR1 into the cytoplasm correlates with a better prognosis of patients with oral squamous cells carcinoma.
J Oral Pathol Med
; 48(2): 108-114, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30489667
5.
Immunohistochemical Analysis Revealed a Correlation between Musashi-2 and Cyclin-D1 Expression in Patients with Oral Squamous Cells Carcinoma.
Int J Mol Sci
; 21(1)2019 Dec 23.
Article
in English
| MEDLINE | ID: mdl-31878037
6.
Sex Hormone Receptors in Benign and Malignant Salivary Gland Tumors: Prognostic and Predictive Role.
Int J Mol Sci
; 19(2)2018 Jan 30.
Article
in English
| MEDLINE | ID: mdl-29385707
7.
Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.
Int J Mol Sci
; 19(9)2018 Sep 08.
Article
in English
| MEDLINE | ID: mdl-30205554
8.
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
BMC Cancer
; 16(1): 918, 2016 11 25.
Article
in English
| MEDLINE | ID: mdl-27884140
9.
Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types.
Int J Mol Sci
; 17(5)2016 May 21.
Article
in English
| MEDLINE | ID: mdl-27213372
10.
Follicular thyroid carcinoma with skull metastases.
Endocr J
; 62(4): 363-9, 2015.
Article
in English
| MEDLINE | ID: mdl-25797278
11.
High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer.
J Cell Physiol
; 229(1): 53-9, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-23765903
12.
Axillary node metastasis from differentiated thyroid carcinoma with Hürthle and signet ring cell differentiation. A case of disseminated thyroid cancer with peculiar histologic findings.
BMC Cancer
; 12: 55, 2012 Feb 03.
Article
in English
| MEDLINE | ID: mdl-22304797
13.
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization.
Cancers (Basel)
; 14(2)2022 Jan 08.
Article
in English
| MEDLINE | ID: mdl-35053468
14.
TLR4 Expression in Ex-Lichenoid Lesions-Oral Squamous Cell Carcinomas and Its Surrounding Epithelium: The Role of Tumor Inflammatory Microenvironment.
Biomolecules
; 12(3)2022 02 28.
Article
in English
| MEDLINE | ID: mdl-35327577
15.
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.
Diagnostics (Basel)
; 12(9)2022 Aug 31.
Article
in English
| MEDLINE | ID: mdl-36140519
16.
Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.
Cancers (Basel)
; 14(7)2022 Apr 06.
Article
in English
| MEDLINE | ID: mdl-35406620
17.
Malignant Sinonasal Tumors: Update on Histological and Clinical Management.
Curr Oncol
; 28(4): 2420-2438, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-34287240
18.
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study.
Cancers (Basel)
; 13(20)2021 Oct 14.
Article
in English
| MEDLINE | ID: mdl-34680301
19.
FEZ1/LZTS1 protein expression in ovarian cancer.
J Cell Physiol
; 222(2): 382-6, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-19885841
20.
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience.
Cells
; 9(4)2020 04 07.
Article
in English
| MEDLINE | ID: mdl-32272732